[1]严坚强 吴俊哲 苏培基 桑莉莉△ 池伟东.二仙汤治疗肝肾不足型绝经后骨质疏松症的临床研究[J].中国中医骨伤科杂志,2020,28(10):17-19,24.
 YAN Jianqiang WU Junzhe SU Peiji SANG Lili CHI Weidong.Clinical Study on Erxian Decoction in the Treatment of Postmenopausal Osteoporosis with Deficiency of Liver and Kidney[J].Chinese Journal of Traditional Medical Traumatology & Orthopedics,2020,28(10):17-19,24.
点击复制

二仙汤治疗肝肾不足型绝经后骨质疏松症的临床研究()
分享到:

《中国中医骨伤科杂志》[ISSN:1005-0205/CN:42-1340/R]

卷:
第28卷
期数:
2020年10期
页码:
17-19,24
栏目:
临床研究
出版日期:
2020-10-10

文章信息/Info

Title:
Clinical Study on Erxian Decoction in the Treatment of Postmenopausal Osteoporosis with Deficiency of Liver and Kidney
文章编号:
1005-0205(2020)10-0017-03
作者:
严坚强1 吴俊哲1 苏培基1 桑莉莉1△ 池伟东1
Author(s):
YAN Jianqiang1 WU Junzhe1 SU Peiji1 SANG Lili1△ CHI Weidong1
1Zhongshan Hospital of Traditional Chinese Medicine,Zhongshan 528400,Guangdong China.
关键词:
绝经后骨质疏松症 二仙汤 细胞因子
Keywords:
postmenopausal osteoporosis Erxian decoction cytokines
分类号:
R274.39
文献标志码:
A
摘要:
目的:通过二仙汤对绝经后骨质疏松症进行临床治疗,客观评价二仙汤对多种细胞因子的作用及临床应用效果。方法:将肝肾不足型的绝经后骨质疏松症患者60例,随机分成治疗组(服用二仙汤)和对照组(每日口服60 mg雷洛昔芬)各30例,治疗周期6个月。记录治疗前后骨密度、疼痛视觉模拟评分(VAS)、白细胞介素1(IL-1)、白细胞介素6(IL-6)、肿瘤坏死因子-α(TNF-α)等细胞因子情况。结果:在VAS评分和骨密度的改善上,两组患者治疗前和治疗结束后差异有统计学意义(P<0.01); IL-1,IL-6和TNF-α的比较汇总,两组患者治疗前和治疗后的骨密度分布差异有统计学意义(P<0.01),但在治疗6个月后,二仙汤组较对照组改善明显。结论:二仙汤对肝肾不足型绝经后骨质疏松症疼痛、骨密度均有一定的改善效果,同时能够降低IL-1,IL-6和TNF-α等细胞因子指标,在IL-6指标改善方面使用雷洛昔芬效果更明显。
Abstract:
To evaluate the effect of Erxian decoction on multiple cytokines and clinical application through the clinical treatment of postmenopausal osteoporosis.Methods: 60 postmenopausal osteoporosis patients with liver and kidney deficiency were randomly divided into treatment group(Erxian decoction)and control group(raloxifene 60 mg once a day), continuous administration for 6 months. There were 30 cases in each group, and the treatment period was 6 months. Before and after treatment, bone mineral density, visual analog score(VAS), interleukin-1(IL-1), interleukin-6(IL-6), tumor necrosis factor-α(TNF-α)and other cytokines were recorded.Results:In the improvement of VAS score and BMD, there was significant difference between the two groups before and after treatment(P<0.01). In the comparison and summary of IL-1, IL-6 and TNF-α, there was significant difference in BMD distribution between the two groups before and after treatment(P<0.01). But after 6 months of treatment, Erxian decoction group were improved significantly compared with the control group.Conclusion:Erxian decoction can improve the pain and bone mineral density of postmenopausal osteoporosis with deficiency of liver and kidney, and reduce the cytokines such as IL-1, IL-6 and TNF-α. In the improvement of IL-6, raloxifene is more effective.

参考文献/References:

[1] 张智海,刘忠厚,李娜,等.中国人骨质疏松症诊断标准专家共识(第三稿·2014版)[J].中国骨质疏松杂志,2014,20(9):1007-1010.
[2] 马远征,王以朋,刘强,等.中国老年骨质疏松症诊疗指南(2018)[J].中国骨质疏松杂志,2018,24(12):1541-1567.
[3] 国家食品药品监督管理局.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002:356-360.
[4] 曹亚飞,刘红敏,刘庆思.骨质疏松症的中医证型与治疗原则探讨[J].中国中医骨伤科杂志,2002,8(4):367.
[5] 黄晋,李建国,谢兴文,等.中药复方治疗绝经后骨质疏松症的临床研究概况[J].中国骨质疏松杂志,2019,25(2):277-280.
[6] 王伟群,吴俊哲,池伟东,等.结合“治未病”思想探讨骨质疏松症[J].光明中医,2018,33(3):297-299.
[7] 顾向晨,韩世盛,徐震宇,等.二丁二仙汤预防去势雌性大鼠泌尿道感染的作用与机制研究[J].中国中西医结合肾病杂志,2014,15(4):338-377.
[8] 卢军,陈燕芬,方米泥,等.仙胶合剂对肝肾阴虚型卵巢早衰患者骨代谢的影响[J].河南中医,2018,38(6):941-944.
[9] 苑成发,闫秀中,房经武,等.杜仲补肾健骨颗粒联合温针灸治疗肾虚精亏型骨质疏松症临床研究[J].河南中医,2017,37(11):1981-1986.
[10] 涂艳,熊莉娜,柳湘洁,等.复方淫羊藿口服液治疗原发性骨质疏松症临床研究[J].中医学报,2017,32(10):1981-1984.
[11] 李家,林晓晟,王雅冰,等.续断皂苷Ⅵ对小鼠骨髓基质干细胞成骨分化的影响[J].口腔颌面修复学杂志,2017,18(1):28-32.
[12] 何玉琼,赵璐,沈燚,等.淫羊藿苷对铁超载模型小鼠骨代谢的影响[J].药学学报,2018,53(7):1100-1107.
[13] 廖悦华,梁琼,王卓,等.中药骨碎补对去睾丸骨质疏松症动物模型的影响[J].中国骨质疏松杂志,2007,13(4):277-280.
[14] 李杨,关雪峰.中药对骨质疏松症骨代谢影响研究进展[J].辽宁中医药大学学报,2019,21(5):1-4.
[15] 刘波,王莹,谢珍,等.二仙汤及其拆方含药血清对成骨细胞分化的影响[J].中药药理与临床,2019,35(1):22-27.
[16] 蒋辉,乐曦,刘东灵,等.加味二仙汤治疗绝经后骨质疏松症35例疗效观察[J].中国药房,2014,25(27):2569-2571.
[17] ZHAO B J,WANG J,SONG J,et al.Beneficial effects of a flavonoid fraction of herba epimedii on bone metabolism in ovariectomized rats[J].Planta Medica,2016,82(4):322-329.

备注/Memo

备注/Memo:
(收稿日期:2020-03-06)基金项目:中山市医学科研项目(2017A020115) 苏培基全国名老中医药专家传承工作室 2018年全国名老中医药专家传承工作室建设项目 1广东中山市中医院(广东 中山,528400) 通信作者 E-mail:18819322148@163.com
更新日期/Last Update: 2020-10-10